MedTrace Logo

Cohort of Non-small Cell Lung Cancer With Mutation of the Nord Pas de Calais (CB(NPC)²)

NCT02448758 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 518

Last updated 2026-03-13

No results posted yet for this study

Summary

The investigators propose to create a database at the regional level, the principle is to include all patients in whom a mutation was detected from a single platform (Lille). The creation of this regional cohort, smaller than the national cohort of Biomarkers France, will perform a more comprehensive collection of clinical data, and molecular monitoring data of patients included. To increase the completeness of the collection of information, it will not be based on voluntary prescribing clinician but will be largely carried out by CRA dedicated to this activity.

Conditions

Sponsors & Collaborators

  • University Hospital, Lille

    collaborator OTHER

  • Centre de Biologie Pathologie : Plateforme de Biologie Moléculaire de Lille

    collaborator UNKNOWN

  • Centre Oscar Lambret

    lead OTHER

Principal Investigators

  • Alexis CORTOT, MD, PhD · CHRU of Lille

  • Eric Dansin, MD · Centre Oscar Lambret

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2016-09-30
Completion
2017-09-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02448758 on ClinicalTrials.gov